OCN Shares Oceana Metals Limited
ASX · ASXLast in our picks 2026-10-01 — not in the current list; analysis below is from that screen
Not a pure biotech, but included only as the closest liquid healthcare adjacent name.
Future value: $0.60 (+50.00%) · 6-12 months
Signal breakdown
- ▸Healthcare exposure exists, but it lacks biotech-specific catalysts.
- ▸Above 50-day MA (+4.49%)
- ▸Volume 1.94× average — accumulation
- ▸~50% upside to price target
Is OCN a buy right now?
Trend: OCN is trading below the 50-day average (-21.62%), RSI 96 — overbought territory, with a 3-month return of -13.43%.
Valuation & quality: Oceana Metals Limited trades on price-to-book 3.87; fundamentals show net margin 0.0%, return on equity -95.1%, revenue growth -66.8% year on year.
Our screen: BUY (score 3) — Not a pure biotech, but included only as the closest liquid healthcare adjacent name.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +0.00% | +11.40% | +22.40% | -13.30% | -34.60% | +26.50% | -14.00% | -21.60% |
Fundamentals
Technical signals
About Oceana Metals Limited
Oceana Metals Limited engages in lithium pegmatite discovery and exploration in Brazil and Australia. It explores for base metals. It acquires 100% of Serra Negra Rare Earths and Niobium Project in Minas Gerais, Brazil.
Sector: Basic Materials · Industry: Other Industrial Metals & Mining · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.